NMT Medical, Inc’s BioSTAR® Featured in First Live Case Demonstration

BOSTON--(BUSINESS WIRE)--NMT Medical, Inc. (Nasdaq: NMTI) announced today that a satellite broadcast of a minimally-invasive septal repair procedure with the Company’s bioabsorbable implant, BioSTAR®, was transmitted live to the Structural Heart Disease Symposium, a combined adult and pediatric interventional cardiology meeting held in Las Vegas, Nevada. The live case was performed on July 25 at the Peter Munk Cardiac Center, Toronto General Hospital in Toronto, Canada.

MORE ON THIS TOPIC